Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Ani Pharmaceuticals has disclosed FCF Payout Ratio across 5 years of filings, most recently posting 0.01 for Q3 2025.

• In Q3 2025, FCF Payout Ratio fell 82.89% year-over-year to 0.01; the TTM figure through Jun 2026 stood at 0.0 (down 84.65% YoY), while the FY2025 annual figure was 0.01, down 80.15% from the prior year.
• FCF Payout Ratio came in at 0.01 for Q3 2025 at Ani Pharmaceuticals, up from 0.01 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 0.35 in Q3 2022 to a low of 0.05 in Q4 2022.
• Average FCF Payout Ratio over 5 years is 0.03, with a median of 0.01 recorded in 2025.
• Year-over-year, FCF Payout Ratio sank 256.38% in 2022 and surged 297.15% in 2024.
• Over 5 years, FCF Payout Ratio stood at 0.02 in 2021, then slumped by 256.38% to 0.05 in 2022, then jumped by 117.71% to 0.01 in 2023, then soared by 215.32% to 0.03 in 2024, then slumped by 69.94% to 0.01 in 2025.
• Per Business Quant data, the three most recent FCF Payout Ratio figures were 0.01 in Q3 2025, 0.01 in Q2 2025, and 0.01 in Q1 2025.